These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9302129)

  • 1. Treatment of Peyronie's disease with intralesional verapamil injection.
    Levine LA
    J Urol; 1997 Oct; 158(4):1395-9. PubMed ID: 9302129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
    Cavallini G; Modenini F; Vitali G
    Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
    Di Stasi SM; Giannantoni A; Stephen RL; Capelli G; Giurioli A; Jannini EA; Vespasiani G
    J Urol; 2004 Apr; 171(4):1605-8. PubMed ID: 15017231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional verapamil for the treatment of Peyronie's disease: a review.
    Levine LA; Estrada CR
    Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
    Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
    J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraplaque verapamil injection for treatment of Peyronie's disease.
    Lasser A; Vandenberg TL; Vincent MJ; Hellstrom WJ
    J La State Med Soc; 1998 Sep; 150(9):431-4. PubMed ID: 9785755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with intraplaque injection of verapamil for Peyronie's disease.
    Levine LA; Goldman KE; Greenfield JM
    J Urol; 2002 Aug; 168(2):621-5; discussion 625-6. PubMed ID: 12131321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining predictors of response to intralesional verapamil injection therapy for Peyronie's disease.
    Moskovic DJ; Alex B; Choi JM; Nelson CJ; Mulhall JP
    BJU Int; 2011 Nov; 108(9):1485-9. PubMed ID: 21733073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoresis for treatment of Peyronie's disease.
    Riedl CR; Plas E; Engelhardt P; Daha K; Pflüger H
    J Urol; 2000 Jan; 163(1):95-9. PubMed ID: 10604323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional verapamil prevents the progression of Peyronie's disease.
    Bennett NE; Guhring P; Mulhall JP
    Urology; 2007 Jun; 69(6):1181-4. PubMed ID: 17572211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
    Rehman J; Benet A; Melman A
    Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
    Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
    Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hyperthermia in the treatment of Peyronie's disease: a preliminary study.
    Perugia G; Liberti M; Vicini P; Colistro F; Gentile V
    Int J Hyperthermia; 2005 Jun; 21(4):367-74. PubMed ID: 16019862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study.
    Riedl CR; Sternig P; Gallé G; Langmann F; Vcelar B; Vorauer K; Wagner A; Katinger H; Pflüger H
    Eur Urol; 2005 Oct; 48(4):656-61. PubMed ID: 15982798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
    Greenfield JM; Shah SJ; Levine LA
    J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
    Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
    Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effects of verapamil in the treatment of Peyronie's disease].
    Arena F; Peracchia G; Di Stefano C; Passari A; Larosa M; Cortellini P
    Acta Biomed Ateneo Parmense; 1995; 66(6):269-72. PubMed ID: 8928594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach.
    Hauck EW; Hauptmann A; Bschleipfer T; Schmelz HU; Altinkilic BM; Weidner W
    J Urol; 2004 Jan; 171(1):296-9. PubMed ID: 14665898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the efficacy of intralesional verapamil versus normal saline injection in a novel Peyronie disease animal model: assessment of immunohistopathological changes and erectile function outcome.
    Chung E; Garcia F; Young LD; Solomon M; Brock GB
    J Urol; 2013 Jan; 189(1):380-4. PubMed ID: 23174244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.